CellCept (Mycophenolate Mofetil) patient information - prescription drugs and medications at RxList

Find a Drug Advanced Search

Professional

CellCept

Patient Information

font size

Give patients complete dosage instructions and inform them about the increased risk of lymphoproliferative disease and certain other malignancies.
Inform patients that they need repeated appropriate laboratory tests while they are taking CellCept.
Inform women of childbearing potential that use of CellCept in pregnancy is associated with an increased risk of first trimester pregnancy loss and an increased risk of birth defects, and that they must use effective contraception.
Discuss pregnancy plans with female patients of childbearing potential.
- Any female of childbearing potential must use highly effective (two methods) contraception 4 weeks prior to starting CellCept therapy and continue contraception until 6 weeks after stopping CellCept treatment, unless abstinence is the chosen method (see WARNINGS: Pregnancy).
- A patient who is planning a pregnancy should not use CellCept unless she cannot be successfully treated with other immunosuppressant drugs.

Brand Name: CellCept
Generic Name: Mycophenolate Mofetil

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Bookmark this page:

Find out what women really need.

Home Dialysis for Kidney Failure
Kidney dialysis for failing kidneys can now be done at home thanks to a new portable machine. See more WebMD Videos »